Amedeo Smart

Free Medical Literature Service



Colorectal Neoplasms

  Free Subscription

Articles published in
Int J Cancer
    May 2018
  1. TAYLOR ES, McCall JL, Shen S, Girardin A, et al
    Prognostic roles for IL-2-producing and CD69(+) T cell subsets in colorectal cancer patients.
    Int J Cancer. 2018 May 11. doi: 10.1002/ijc.31598.
    >> Share

    April 2018
  2. MURPHY N, Achaintre D, Zamora-Ros R, Jenab M, et al
    A Prospective Evaluation of Plasma Polyphenol Levels and Colon Cancer Risk.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31563.
    >> Share

  3. CHEN L, Pan X, Hu X, Zhang YH, et al
    Gene expression differences among different MSI statuses in colorectal cancer.
    Int J Cancer. 2018 Apr 26. doi: 10.1002/ijc.31554.
    >> Share

  4. BARRUBES L, Babio N, Mena-Sanchez G, Toledo E, et al
    Dairy product consumption and risk of colorectal cancer in an older Mediterranean population at high cardiovascular risk.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31540.
    >> Share

  5. TRIFF K, McLean MW, Callaway E, Goldsby J, et al
    Dietary fat and fiber interact to uniquely modify global histone post-translational epigenetic programming in a rat colon cancer progression model.
    Int J Cancer. 2018 Apr 16. doi: 10.1002/ijc.31525.
    >> Share

  6. LIU X, Zhou W, Zhang X, Ding Y, et al
    1-L-MT, an IDO inhibitor, prevented colitis-associated cancer by inducing CDC20 inhibition-mediated mitotic death of colon cancer cells.
    Int J Cancer. 2018 Apr 1. doi: 10.1002/ijc.31417.
    >> Share

    March 2018
  7. LI X, Guo X, Li D, Du X, et al
    Multi-regional Sequencing Reveals Intratumor Heterogeneity and Positive Selection of Somatic mtDNA Mutations in Hepatocellular Carcinoma and Colorectal Cancer.
    Int J Cancer. 2018 Mar 23. doi: 10.1002/ijc.31395.
    >> Share

  8. FADDA A, Gentilini D, Moi L, Barault L, et al
    Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.
    Int J Cancer. 2018 Mar 15. doi: 10.1002/ijc.31380.
    >> Share

  9. ZHOU M, Liu X, Li Z, Huang Q, et al
    Caspase-3 regulates the migration, invasion, and metastasis of colon cancer cells.
    Int J Cancer. 2018 Mar 10. doi: 10.1002/ijc.31374.
    >> Share

  10. PAN P, Oshima K, Huang YW, Agle KA, et al
    Loss of FFAR2 promotes colon cancer by epigenetic dysregulation of inflammation suppressors.
    Int J Cancer. 2018 Mar 9. doi: 10.1002/ijc.31366.
    >> Share

    February 2018
  11. MARQUEZ J, Fernandez-Pineiro I, Arauzo-Bravo MJ, Poschmann G, et al
    Targeting liver sinusoidal endothelial cells with miR-20a-loaded nanoparticles reduces murine colon cancer metastasis to the liver.
    Int J Cancer. 2018 Feb 28. doi: 10.1002/ijc.31343.
    >> Share

  12. KABAT GC, Kim MY, Stefanick M, Ho GYF, et al
    Metabolic obesity phenotypes and risk of colorectal cancer in postmenopausal women.
    Int J Cancer. 2018 Feb 27. doi: 10.1002/ijc.31345.
    >> Share

  13. SHU X, Xiang YB, Rothman N, Yu D, et al
    Prospective study of blood metabolites associated with colorectal cancer risk.
    Int J Cancer. 2018 Feb 26. doi: 10.1002/ijc.31341.
    >> Share

  14. WU S, Meng Q, Zhang C, Sun H, et al
    DR4 mediates the progression, invasion, metastasis and survival of colorectal cancer through the Sp1/NF1 switch axis on genomic locus.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31318.
    >> Share

  15. KASHINO I, Akter S, Mizoue T, Sawada N, et al
    Coffee drinking and colorectal cancer and its subsites: A pooled analysis of 8 cohort studies in Japan.
    Int J Cancer. 2018 Feb 15. doi: 10.1002/ijc.31320.
    >> Share

  16. LEW JB, James D, St John B, Macrae FA, et al
    Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31314.
    >> Share

  17. AMSHOFF Y, Maskarinec G, Shvetsov YB, Raquinio PH, et al
    Type 2 Diabetes and Colorectal Cancer Survival: The Multiethnic Cohort.
    Int J Cancer. 2018 Feb 14. doi: 10.1002/ijc.31311.
    >> Share

  18. SCHULLEHNER J, Hansen B, Thygesen M, Pedersen CB, et al
    Nitrate in drinking water and colorectal cancer risk: A nationwide population-based cohort study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31306.
    >> Share

  19. FRANSGAARD T, Thygesen LC, Gogenur I
    Association between metformin use after surgery for colorectal cancer and oncological outcomes: A nationwide register-based study.
    Int J Cancer. 2018 Feb 13. doi: 10.1002/ijc.31305.
    >> Share

    January 2018
  20. O'BRIEN SJ, Carter JV, Burton JF, Oxford BG, et al
    The role of the miR-200 Family in Epithelial-Mesenchymal Transition in Colorectal Cancer: A Systematic Review.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31282.
    >> Share

  21. ISHIKAWA T, Okayama T, Sakamoto N, Ideno M, et al
    Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer.
    Int J Cancer. 2018 Jan 31. doi: 10.1002/ijc.31285.
    >> Share

  22. BUTT J, Jenab M, Willhauck-Fleckenstein M, Michel A, et al
    Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancer.
    Int J Cancer. 2018 Jan 29. doi: 10.1002/ijc.31283.
    >> Share

  23. MA H, Wu Z, Peng J, Li Y, et al
    Inhibition of SLC1A5 sensitizes colorectal cancer to cetuximab.
    Int J Cancer. 2018 Jan 24. doi: 10.1002/ijc.31274.
    >> Share

  24. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Ball IA, et al
    Dacomitinib-induced diarrhea: Targeting chloride secretion with crofelemer.
    Int J Cancer. 2018;142:369-380.
    >> Share

  25. BASU P, Ponti A, Anttila A, Ronco G, et al
    Status of implementation and organization of cancer screening in The European Union Member States-Summary results from the second European screening report.
    Int J Cancer. 2018;142:44-56.
    >> Share

    December 2017
  26. GIES A, Bhardwaj M, Stock C, Schrotz-King P, et al
    Quantitative Fecal Immunochemical Tests for Colorectal Cancer Screening.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31233.
    >> Share

  27. LIU W, Wang S, Sun Q, Yang Z, et al
    DCLK1 Promotes Epithelial-Mesenchymal Transition via the PI3K/Akt/NF-kappaB Pathway in Colorectal Cancer.
    Int J Cancer. 2017 Dec 26. doi: 10.1002/ijc.31232.
    >> Share

  28. JI J, Sundquist J, Sundquist K
    Use of hormone replacement therapy improves the prognosis in patients with colorectal cancer: A population-based study in Sweden.
    Int J Cancer. 2017 Dec 22. doi: 10.1002/ijc.31228.
    >> Share

  29. FENG HC, Lin JY, Hsu SH, Lan WY, et al
    Low folate metabolic stress reprograms DNA methylation-activated sonic hedgehog signaling to mediate cancer stem cell-like signatures and invasive tumour stage-specific malignancy of human colorectal cancers.
    Int J Cancer. 2017;141:2537-2550.
    >> Share

  30. ZHOU R, Shao Z, Liu J, Zhan W, et al
    COPS5 and LASP1 Synergistically Interact to Down-regulate 14-3-3sigma Expression and Promote Colorectal Cancer Progression via Activating PI3K/AKT Pathway.
    Int J Cancer. 2017 Dec 11. doi: 10.1002/ijc.31206.
    >> Share

  31. SCHWINGSHACKL L, Schwedhelm C, Hoffmann G, Knuppel S, et al
    Food groups and risk of colorectal cancer.
    Int J Cancer. 2017 Dec 6. doi: 10.1002/ijc.31198.
    >> Share

  32. RAY AL, Berggren KL, Restrepo Cruz S, Gan GN, et al
    Inhibition of MK2 suppresses IL-1beta, IL-6, and TNF-alpha dependent colorectal cancer growth.
    Int J Cancer. 2017 Dec 2. doi: 10.1002/ijc.31191.
    >> Share

    November 2017
  33. BABAEI M, Balavarca Y, Jansen L, Lemmens V, et al
    Administration of Adjuvant Chemotherapy for Stage II-III Colon Cancer Patients: A European Population-based Study.
    Int J Cancer. 2017 Nov 21. doi: 10.1002/ijc.31168.
    >> Share

  34. YAMAUCHI M, Urabe Y, Ono A, Miki D, et al
    Serial profiling of circulating tumor DNA for optimization of anti-VEGF chemotherapy in metastatic colorectal cancer patients.
    Int J Cancer. 2017 Nov 14. doi: 10.1002/ijc.31154.
    >> Share

  35. DI J, Yang H, Jiang B, Wang Z, et al
    Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer.
    Int J Cancer. 2017 Nov 6. doi: 10.1002/ijc.31140.
    >> Share

    October 2017
  36. ZHANG QL, Zhao LG, Li HL, Gao J, et al
    The joint effects of major lifestyle factors on colorectal cancer risk among Chinese men: A prospective cohort study.
    Int J Cancer. 2017 Oct 21. doi: 10.1002/ijc.31126.
    >> Share

  37. HOLCH JW, Ricard I, Stintzing S, Fischer von Weikersthal L, et al
    Relevance of liver-limited disease in metastatic colorectal cancer: Subgroup findings of the FIRE-3/AIO KRK0306 trial.
    Int J Cancer. 2017 Oct 19. doi: 10.1002/ijc.31114.
    >> Share

  38. NIELL N, Larriba MJ, Ferrer-Mayorga G, Sanchez-Perez I, et al
    The human PKP2/Plakophilin-2 gene is induced by Wnt/beta-catenin in normal and colon cancer-associated fibroblasts.
    Int J Cancer. 2017 Oct 16. doi: 10.1002/ijc.31104.
    >> Share

  39. HIDAYAT K, Yang CM, Shi BM
    Body Fatness at an Early Age and Risk of Colorectal Cancer.
    Int J Cancer. 2017 Oct 12. doi: 10.1002/ijc.31100.
    >> Share

  40. PAN R, Zhu M, Yu C, Lv J, et al
    Cancer incidence and mortality: A cohort study in China, 2008-2013.
    Int J Cancer. 2017;141:1315-1323.
    >> Share

  41. VARGAS-PARRA GM, Gonzalez-Acosta M, Thompson BA, Gomez C, et al
    Elucidating the molecular basis of MSH2-deficient tumors by combined germline and somatic analysis.
    Int J Cancer. 2017;141:1365-1380.
    >> Share

    September 2017
  42. TANSKANEN T, van den Berg L, Valimaki N, Aavikko M, et al
    Genome-wide association study and meta-analysis in Northern European populations replicate multiple colorectal cancer risk loci.
    Int J Cancer. 2017 Sep 28. doi: 10.1002/ijc.31076.
    >> Share

  43. POTHOULAKIS C, Torre-Rojas M, Duran-Padilla MA, Gevorkian J, et al
    CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Int J Cancer. 2017 Sep 20. doi: 10.1002/ijc.31064.
    >> Share

  44. WANG W, Xiao X, Chen X, Huo Y, et al
    Tumor-suppressive miR-145 co-repressed by TCF4-beta-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31056.
    >> Share

  45. JAYASEKARA H, English DR, Haydon A, Hodge AM, et al
    Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype.
    Int J Cancer. 2017 Sep 16. doi: 10.1002/ijc.31049.
    >> Share

  46. HASENOEHRL C, Feuersinger D, Sturm EM, Barnthaler T, et al
    G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1.
    Int J Cancer. 2017 Sep 5. doi: 10.1002/ijc.31030.
    >> Share

  47. MA B, Gao P, Wang H, Xu Q, et al
    What has preoperative radio(chemo)therapy brought to localized rectal cancer patients in terms of perioperative and long-term outcomes over the past decades? A systematic review and meta-analysis based on 41,121 patients.
    Int J Cancer. 2017;141:1052-1065.
    >> Share

  48. VEDELD HM, Merok M, Jeanmougin M, Danielsen SA, et al
    CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers.
    Int J Cancer. 2017;141:967-976.
    >> Share

    August 2017
  49. MOMEN-HERAVI F, Masugi Y, Qian ZR, Nishihara R, et al
    Tumor Expression of Calcium Sensing Receptor (CASR) and Colorectal Cancer Survival: Results from the Nurses' Health Study and Health Professionals Follow-Up Study.
    Int J Cancer. 2017 Aug 30. doi: 10.1002/ijc.31021.
    >> Share

  50. EKLOF V, Lofgren-Burstrom A, Zingmark C, Edin S, et al
    Cancer associated faecal microbial markers in colorectal cancer detection.
    Int J Cancer. 2017 Aug 22. doi: 10.1002/ijc.31011.
    >> Share

  51. CESPEDES FELICIANO EM, Prentice RL, Aragaki AK, Neuhouser ML, et al
    Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative.
    Int J Cancer. 2017 Aug 18. doi: 10.1002/ijc.30931.
    >> Share

  52. MEESTER RGS, Doubeni CA, Zauber AG, van Ballegooijen M, et al
    Impact of Adenoma Detection on the Benefit of Faecal Testing versus Colonoscopy for Colorectal Cancer.
    Int J Cancer. 2017 Aug 17. doi: 10.1002/ijc.30933.
    >> Share

  53. JUBRAN R, Kocsis J, Garam N, Malati E, et al
    Circulating mitochondrial Stress-70 protein/mortalin and cytosolic Hsp70 in blood: Risk indicators in colorectal cancer.
    Int J Cancer. 2017 Aug 9. doi: 10.1002/ijc.30918.
    >> Share

    July 2017
  54. JIAO W, Leng X, Zhou Q, Wu Y, et al
    Different miR-21-3p isoforms and their different features in colorectal cancer.
    Int J Cancer. 2017 Jul 22. doi: 10.1002/ijc.30902.
    >> Share

  55. SCHIRRIPA M, Zhang W, Heinemann V, Cao S, et al
    Single nucleotide polymorphisms in the IGF-IRS pathway are associated with outcome in mCRC patients enrolled in the FIRE-3 trial.
    Int J Cancer. 2017;141:383-392.
    >> Share

  56. GU F, Zhang H, Hyland PL, Berndt S, et al
    Inherited variation in circadian rhythm genes and risks of prostate cancer and three other cancer sites in combined cancer consortia.
    Int J Cancer. 2017 Jul 12. doi: 10.1002/ijc.30883.
    >> Share

  57. BERNTSSON J, Svensson MC, Leandersson K, Nodin B, et al
    The Clinical Impact of Tumour-infiltrating Lymphocytes in Colorectal Cancer Differs by Anatomical Subsite: A Cohort Study.
    Int J Cancer. 2017 Jul 5. doi: 10.1002/ijc.30869.
    >> Share

  58. KRILAVICIUTE A, Stock C, Brenner H
    International variation in the prevalence of preclinical colorectal cancer: Implications for predictive values of noninvasive screening tests and potential target populations for screening.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30867.
    >> Share

  59. ALAM KJ, Mo JS, Han SH, Park WC, et al
    MicroRNA 375 regulates proliferation and migration of colon cancer cells by suppressing the CTGF-EGFR signaling pathway.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30861.
    >> Share

  60. CABEL L, Bidard FC, Servois V, Cacheux W, et al
    HPV circulating tumor DNA to monitor the efficacy of anti-PD-1 therapy in metastatic squamous cell carcinoma of the anal canal: A case report.
    Int J Cancer. 2017 Jul 3. doi: 10.1002/ijc.30863.
    >> Share

    June 2017
  61. LAUDATO S, Patil N, Abba ML, Leupold JH, et al
    P53-induced miR-30e-5p inhibits colorectal cancer invasion and metastasis by targeting ITGA6 and ITGB1.
    Int J Cancer. 2017 Jun 28. doi: 10.1002/ijc.30854.
    >> Share

  62. VAN SEBILLE YZA, Gibson RJ, Wardill HR, Secombe KR, et al
    Dacomitinib-induced diarrhoea is associated with altered gastrointestinal permeability and disruption in ileal histology in rats.
    Int J Cancer. 2017;140:2820-2829.
    >> Share

  63. YANG Y, Wang G, He J, Ren S, et al
    Gender differences in colorectal cancer survival: A Meta-analysis.
    Int J Cancer. 2017 Jun 9. doi: 10.1002/ijc.30827.
    >> Share

    May 2017
  64. OKAZAKI S, Stintzing S, Sunakawa Y, Cao S, et al
    Predictive value of TLR7 polymorphism for cetuximab-based chemotherapy in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30810.
    >> Share

  65. WANG N, Lu Y, Khankari NK, Long J, et al
    Evaluation of genetic variants in association with colorectal cancer risk and survival in Asians.
    Int J Cancer. 2017 May 31. doi: 10.1002/ijc.30812.
    >> Share

  66. CANAVESE M, Ngo DT, Maddern GJ, Hardingham JE, et al
    Biology and therapeutic implications of VEGF-A splice isoforms and single-nucleotide polymorphisms in colorectal cancer.
    Int J Cancer. 2017;140:2183-2191.
    >> Share

  67. SNAEBJORNSSON P, Jonasson L, Olafsdottir EJ, van Grieken NCT, et al
    Why is colon cancer survival improving by time? A nationwide survival analysis spanning 35 years.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30766.
    >> Share

  68. BUTT J, Werner S, Willhauck-Fleckenstein M, Michel A, et al
    Serology of Streptococcus gallolyticus subspecies gallolyticus and its association with colorectal cancer and precursors.
    Int J Cancer. 2017 May 6. doi: 10.1002/ijc.30765.
    >> Share

  69. BRENNER H, Niedermaier T, Chen H
    Strong subsite-specific variation in detecting advanced adenomas by fecal immunochemical testing for hemoglobin.
    Int J Cancer. 2017;140:2015-2022.
    >> Share

    April 2017
  70. BJERRUM A, Andersen O, Fischer A, Lindebjerg J, et al
    Long term risk of colorectal cancer after negative colonoscopy in a Danish gFOBT screening cohort.
    Int J Cancer. 2017 Apr 30. doi: 10.1002/ijc.30756.
    >> Share

  71. SENDA NAKAGAWA H, Ito H, Hosono S, Oze I, et al
    Coffee consumption and the risk of colorectal cancer by anatomical subsite in Japan: Results from the HERPACC studies.
    Int J Cancer. 2017 Apr 20. doi: 10.1002/ijc.30746.
    >> Share

  72. MODEST DP, Stintzing S, Fischer von Weikersthal L, Decker T, et al
    Relation of early tumor shrinkage (ETS) observed in first-line treatment to efficacy parameters of subsequent treatment in FIRE-3 (AIOKRK0306).
    Int J Cancer. 2017;140:1918-1925.
    >> Share

  73. BEDIN C, Enzo MV, Del Bianco P, Pucciarelli S, et al
    Diagnostic and prognostic role of cell-free DNA testing for colorectal cancer patients.
    Int J Cancer. 2017;140:1888-1898.
    >> Share

  74. ROMAGUERA D, Gracia-Lavedan E, Molinuevo A, de Batlle J, et al
    Adherence to nutrition-based cancer prevention guidelines and breast, prostate and colorectal cancer risk in the MCC-Spain case-control study.
    Int J Cancer. 2017 Apr 5. doi: 10.1002/ijc.30722.
    >> Share

  75. JANSEN L, Weberpals J, Kuiper JG, Vissers PA, et al
    Pre- and post-diagnostic beta-blocker use and prognosis after colorectal cancer: Results from a population-based study.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30717.
    >> Share

  76. JAYASEKARA H, MacInnis RJ, Williamson EJ, Hodge AM, et al
    Lifetime alcohol intake is associated with an increased risk of KRAS+ and BRAF-/KRAS- but not BRAF+ colorectal cancer.
    Int J Cancer. 2017;140:1485-1493.
    >> Share

  77. KUAN FC, Lai CH, Ku HY, Wu CF, et al
    The survival impact of delayed surgery and adjuvant chemotherapy on stage II/III rectal cancer with pathological complete response after neoadjuvant chemoradiation.
    Int J Cancer. 2017;140:1662-1669.
    >> Share

  78. DE MARTEL C, Plummer M, Vignat J, Franceschi S, et al
    Worldwide burden of cancer attributable to HPV by site, country and HPV type.
    Int J Cancer. 2017 Apr 1. doi: 10.1002/ijc.30716.
    >> Share

    March 2017
  79. RODRIGUEZ-BROADBENT H, Law PJ, Sud A, Palin K, et al
    Mendelian randomisation implicates hyperlipidaemia as a risk factor for colorectal cancer.
    Int J Cancer. 2017 Mar 24. doi: 10.1002/ijc.30709.
    >> Share

  80. ZHU XH, Wang JM, Yang SS, Wang FF, et al
    Down-regulation of DAB2IP promotes colorectal cancer invasion and metastasis by translocating hnRNPK into nucleus to enhance the transcription of MMP2.
    Int J Cancer. 2017 Mar 23. doi: 10.1002/ijc.30701.
    >> Share

  81. ZHANG L, Li L, Gao G, Wei G, et al
    Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Int J Cancer. 2017 Mar 17. doi: 10.1002/ijc.30698.
    >> Share

  82. DIETER SM, Giessler KM, Kriegsmann M, Dubash TD, et al
    Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation.
    Int J Cancer. 2017;140:1356-1363.
    >> Share

  83. WILHELMSEN M, Christensen IJ, Rasmussen L, Jorgensen LN, et al
    Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
    Int J Cancer. 2017;140:1436-1446.
    >> Share

  84. WANG H, Schmit SL, Haiman CA, Keku TO, et al
    Novel colon cancer susceptibility variants identified from a genome-wide association study in African Americans.
    Int J Cancer. 2017 Mar 13. doi: 10.1002/ijc.30687.
    >> Share

  85. FIDLER MM, Bray F, Vaccarella S, Soerjomataram I, et al
    Assessing global transitions in human development and colorectal cancer incidence.
    Int J Cancer. 2017 Mar 9. doi: 10.1002/ijc.30686.
    >> Share

  86. KEUM N, Yuan C, Nishihara R, Zoltick E, et al
    Dietary glycemic and insulin scores and colorectal cancer survival by tumor molecular biomarkers.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30683.
    >> Share

    February 2017
  87. KIRANA C, Ruszkiewicz A, Stubbs RS, Hardingham JE, et al
    Soluble HLA-G is a differential prognostic marker in sequential colorectal cancer disease stages.
    Int J Cancer. 2017 Feb 24. doi: 10.1002/ijc.30667.
    >> Share

  88. JERZAK KJ, Berry S, Ko YJ, Earle C, et al
    Cetuximab plus Irinotecan versus Panitumumab in Patients with refractory metastatic colorectal cancer in Ontario, Canada.
    Int J Cancer. 2017 Feb 21. doi: 10.1002/ijc.30637.
    >> Share

  89. ZHANG D, Zhao L, Shen Q, Lv Q, et al
    Down-regulation of KIAA1199/CEMIP by miR-216a suppresses tumor invasion and metastasis in colorectal cancer.
    Int J Cancer. 2017 Feb 18. doi: 10.1002/ijc.30656.
    >> Share

  90. FASANELLI F, Zugna D, Giraudo MT, Krogh V, et al
    Abdominal adiposity is not a mediator of the protective effect of Mediterranean Diet on colorectal cancer.
    Int J Cancer. 2017 Feb 16. doi: 10.1002/ijc.30653.
    >> Share

  91. MORRIS SM, Davison J, Carter KT, O'Leary RM, et al
    Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.
    Int J Cancer. 2017;140:853-863.
    >> Share

  92. CUBIELLA J, Digby J, Rodriguez-Alonso L, Vega P, et al
    The FAST (Faecal Haemoglobin Concentration, Age and Sex Test) Score: Development and external validation of a simple prediction tool for colorectal cancer detection in symptomatic patients.
    Int J Cancer. 2017 Feb 10. doi: 10.1002/ijc.30639.
    >> Share

    January 2017
  93. HERBST A, Vdovin N, Gacesa S, Philipp A, et al
    Methylated free-circulating HPP1 DNA is an early response marker in patients with metastatic colorectal cancer.
    Int J Cancer. 2017 Jan 25. doi: 10.1002/ijc.30625.
    >> Share

  94. WALTER V, Jansen L, Knebel P, Chang-Claude J, et al
    Physical activity and survival of colorectal cancer patients: Population-based study from Germany.
    Int J Cancer. 2017 Jan 24. doi: 10.1002/ijc.30619.
    >> Share

  95. ERTEM FU, Zhang W, Chang K, Mohaiza Dashwood W, et al
    Oncogenic targets Mmp7, S100a9, Nppb and Aldh1a3 from transcriptome profiling of FAP and Pirc adenomas are downregulated in response to tumor suppression by Clotam.
    Int J Cancer. 2017;140:460-468.
    >> Share

    December 2016
  96. ZAMORA-ROS R, Barupal D, Rothwell JA, Jenab M, et al
    Dietary Flavonoid Intake and Colorectal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) Cohort.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30582.
    >> Share

  97. SEFRIOUI D, Vermeulin T, Blanchard F, Chapusot C, et al
    Copy Number Variations in DCC/18q and ERBB2/17q are Associated with Disease-Free Survival in Microsatellite Stable Colon Cancer.
    Int J Cancer. 2016 Dec 22. doi: 10.1002/ijc.30584.
    >> Share

  98. MORI K, Toiyama Y, Otake K, Fujikawa H, et al
    Proteomics analysis of differential protein expression identifies Heat shock protein 47 as a predictive marker for lymph node metastasis in patients with colorectal cancer.
    Int J Cancer. 2016 Dec 7. doi: 10.1002/ijc.30557.
    >> Share

  99. WANG C, Wang Z, Zhou J, Liu S, et al
    TUC.338 promotes invasion and metastasis in colorectal cancer.
    Int J Cancer. 2016 Dec 3. doi: 10.1002/ijc.30542.
    >> Share

    November 2016
  100. BURON PUST A, Alison R, Blanks R, Pirie K, et al
    Heterogeneity of colorectal cancer risk by tumour characteristics: Large prospective study of UK women.
    Int J Cancer. 2016 Nov 18. doi: 10.1002/ijc.30527.
    >> Share

  101. ALGARS A, Sundstrom J, Lintunen M, Jokilehto T, et al
    EGFR gene copy number predicts response to anti-EGFR treatment in RAS wild type and RAS/BRAF/PIK3CA wild type metastatic colorectal cancer.
    Int J Cancer. 2016 Nov 5. doi: 10.1002/ijc.30507.
    >> Share

  102. CHEN Y, Xie Y, Xu L, Zhan S, et al
    Protein content and functional characteristics of serum-purified exosomes from patients with colorectal cancer revealed by quantitative proteomics.
    Int J Cancer. 2016 Nov 3. doi: 10.1002/ijc.30496.
    >> Share

    October 2016
  103. MOMEN-HERAVI F, Babic A, Tworoger SS, Zhang L, et al
    Periodontal disease, tooth loss, and colorectal cancer risk: Results from the Nurses' Health Study.
    Int J Cancer. 2016 Oct 25. doi: 10.1002/ijc.30486.
    >> Share

  104. TRABERT B, Eldridge RC, Pfeiffer RM, Shiels MS, et al
    Pre-diagnostic circulating inflammation markers and endometrial cancer risk in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.
    Int J Cancer. 2016 Oct 22. doi: 10.1002/ijc.30478.
    >> Share

  105. WANG N, Khankari NK, Cai H, Li HL, et al
    Pre-diagnosis Body Mass Index and Waist-Hip Circumference Ratio in Association with Colorectal Cancer Survival.
    Int J Cancer. 2016 Oct 5. doi: 10.1002/ijc.30459.
    >> Share

    September 2016
  106. SCLAFANI F, Kim TY, Cunningham D, Kim TW, et al
    Dalotuzumab in chemorefractory KRAS exon 2 mutant colorectal cancer: Results from a randomised phase II/III trial.
    Int J Cancer. 2016 Sep 28. doi: 10.1002/ijc.30453.
    >> Share

  107. SIMONS CC, Schouten LJ, Godschalk RW, van Engeland M, et al
    Energy restriction at young age, genetic variants in the insulin-like growth factor pathway and colorectal cancer risk in the Netherlands Cohort Study.
    Int J Cancer. 2016 Sep 20. doi: 10.1002/ijc.30439.
    >> Share

  108. MAIERTHALER M, Benner A, Hoffmeister M, Surowy H, et al
    Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Int J Cancer. 2016 Sep 15. doi: 10.1002/ijc.30433.
    >> Share

  109. VAN ERNING FN, Janssen-Heijnen ML, Creemers GJ, Pruijt JF, et al
    Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy.
    Int J Cancer. 2016 Sep 12. doi: 10.1002/ijc.30423.
    >> Share

  110. PARK C, Kim JI, Hong SN, Jung HM, et al
    A copy number variation in PKD1L2 is associated with colorectal cancer predisposition in Korean population.
    Int J Cancer. 2016 Sep 8. doi: 10.1002/ijc.30421.
    >> Share

    August 2016
  111. PENG F, Hu D, Lin X, Chen G, et al
    Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
    Int J Cancer. 2016 Aug 25. doi: 10.1002/ijc.30404.
    >> Share

  112. LI Q, Wei P, Huang B, Xu Y, et al
    MAEL expression links epithelial-mesenchymal transition and stem cell properties in colorectal cancer.
    Int J Cancer. 2016 Aug 18. doi: 10.1002/ijc.30388.
    >> Share

  113. HASHIMOTO M, Kobayashi T, Tashiro H, Arihiro K, et al
    h-Prune is associated with poor prognosis and epithelial-mesenchymal transition in patients with colorectal liver metastases.
    Int J Cancer. 2016;139:812-23.
    >> Share

  114. TAKAHASHI Y, Sugai T, Habano W, Ishida K, et al
    Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.
    Int J Cancer. 2016 Aug 10. doi: 10.1002/ijc.30377.
    >> Share

    July 2016
  115. JARY M, Lecomte T, Bouche O, Kim S, et al
    Prognostic value of baseline seric Syndecan-1 in initially unresectable metastatic colorectal cancer patients: A simple biological score.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30367.
    >> Share

  116. SALIMZADEH H, Bishehsari F, Amani M, Ansari R, et al
    Advanced Colonic Neoplasia in the First Degree Relatives of Colon Cancer Patients: A Colonoscopy-based Study.
    Int J Cancer. 2016 Jul 29. doi: 10.1002/ijc.30366.
    >> Share

  117. ZHANG X, Keum N, Wu K, Smith-Warner SA, et al
    Calcium intake and colorectal cancer risk: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jul 28. doi: 10.1002/ijc.30293.
    >> Share

  118. WEIGL K, Jansen L, Chang-Claude J, Knebel P, et al
    Family history and the risk of colorectal cancer: The importance of patients' history of colonoscopy.
    Int J Cancer. 2016 Jul 26. doi: 10.1002/ijc.30284.
    >> Share

  119. SOREIDE K
    Resection of asymptomatic primary tumour in unresectable stage IV colorectal cancer: time to move on from propensity matched scores to randomized controlled trials.
    Int J Cancer. 2016 Jul 12. doi: 10.1002/ijc.30244.
    >> Share

  120. KAHLERT UD, Mooney SM, Natsumeda M, Steiger HJ, et al
    Targeting Cancer Stem-like Cells in Glioblastoma and Colorectal Cancer through Metabolic Pathways.
    Int J Cancer. 2016 Jul 8. doi: 10.1002/ijc.30259.
    >> Share

    June 2016
  121. KANTOR ED, Zhang X, Wu K, Signorello LB, et al
    Use of glucosamine and chondroitin supplements in relation to risk of colorectal cancer: Results from the Nurses' Health Study and Health Professionals Follow-up Study.
    Int J Cancer. 2016 Jun 30. doi: 10.1002/ijc.30250.
    >> Share

  122. LAM-BOER J', Van der Geest LG, Verhoef C, Elferink ME, et al
    Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population-based propensity-score adjusted study in The Netherlands.
    Int J Cancer. 2016 Jun 24. doi: 10.1002/ijc.30240.
    >> Share

  123. MEULENDIJKS D, Henricks LM, Amstutz U, Froehlich TK, et al
    Rs895819 in MIR27A improves the predictive value of DPYD variants to identify patients at risk of severe fluoropyrimidine-associated toxicity.
    Int J Cancer. 2016;138:2752-61.
    >> Share

  124. ALLAIRE JM, Roy SA, Ouellet C, Lemieux E, et al
    Bmp signaling in colonic mesenchyme regulates stromal microenvironment and protects from polyposis initiation.
    Int J Cancer. 2016;138:2700-12.
    >> Share

    May 2016
  125. DUFFY AG, Makarova-Rusher OV, Ulahannan SV, Rahma OE, et al
    Modulation of tumor eIF4E by antisense inhibition: A phase I/II translational clinical trial of ISIS 183750 - an antisense oligonucleotide against eIF4E - in combination with irinotecan in solid tumors and irinotecan-refractory colorectal cancer.
    Int J Cancer. 2016 May 19. doi: 10.1002/ijc.30199.
    >> Share

    April 2016
  126. VILLACIS RA, Miranda PM, Gomy I, Santos EM, et al
    Contribution of rare germline copy number variations and common susceptibility loci in Lynch syndrome patients negative for mutations in the mismatch repair genes.
    Int J Cancer. 2016;138:1928-35.
    >> Share

  127. UBILLOS L, Freire T, Berriel E, Chiribao ML, et al
    Trypanosoma cruzi extracts elicit protective immune response against chemically induced colon and mammary cancers.
    Int J Cancer. 2016;138:1719-31.
    >> Share

  128. EEFSEN RL, Engelholm L, Willemoe GL, Van den Eynden GG, et al
    Microvessel density and endothelial cell proliferation levels in colorectal liver metastases from patients given neo-adjuvant cytotoxic chemotherapy and bevacizumab.
    Int J Cancer. 2016;138:1777-84.
    >> Share

  129. SAKAI E, Fukuyo M, Ohata K, Matsusaka K, et al
    Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Int J Cancer. 2016;138:1634-44.
    >> Share

    March 2016
  130. LOES IM, Immervoll H, Sorbye H, Angelsen JH, et al
    Impact of KRAS, BRAF, PIK3CA, TP53 status and intra-individual mutation heterogeneity on outcome after liver resection for colorectal cancer metastases.
    Int J Cancer. 2016 Mar 16. doi: 10.1002/ijc.30089.
    >> Share

  131. KANGWAN N, Kim YJ, Han YM, Jeong M, et al
    Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.
    Int J Cancer. 2016;138:1482-93.
    >> Share

  132. RENAUD F, Mariette C, Vincent A, Wacrenier A, et al
    The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Int J Cancer. 2016;138:1472-81.
    >> Share

  133. IZANO M, Wei EK, Tai C, Swede H, et al
    Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
    Int J Cancer. 2016;138:1118-28.
    >> Share

  134. DE CUBA EM, Snaebjornsson P, Heideman DA, van Grieken NC, et al
    Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
    Int J Cancer. 2016;138:1139-45.
    >> Share

  135. BU Y, Li X, He Y, Huang C, et al
    A phosphomimetic mutant of RelA/p65 at Ser536 induces apoptosis and senescence: An implication for tumor-suppressive role of Ser536 phosphorylation.
    Int J Cancer. 2016;138:1186-98.
    >> Share

    February 2016
  136. MEGE D, Panicot-Dubois L, Ouaissi M, Robert S, et al
    The origin and concentration of circulating microparticles differ according to cancer type and evolution: A prospective single-center study.
    Int J Cancer. 2016;138:939-48.
    >> Share

    January 2016
  137. HOBAUS J, Tennakoon S, Heffeter P, Groeschel C, et al
    Impact of CYP24A1 overexpression on growth of colorectal tumour xenografts in mice fed with vitamin D and soy.
    Int J Cancer. 2016;138:440-50.
    >> Share

  138. CARR PR, Walter V, Brenner H, Hoffmeister M, et al
    Meat subtypes and their association with colorectal cancer: Systematic review and meta-analysis.
    Int J Cancer. 2016;138:293-302.
    >> Share

    August 2015
  139. AMAYIRI N, Tabori U, Campbell B, Bakry D, et al
    High frequency of mismatch repair deficiency among pediatric high grade gliomas in Jordan.
    Int J Cancer. 2015 Aug 8. doi: 10.1002/ijc.29724.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016